GREY:MPHMF - Post by User
Post by
ezcostelloon Jul 12, 2017 11:50am
64 Views
Post# 26460151
Orlistat
OrlistatJust want to bring up a valid point about the drug. Two days ago Orlistat got placed on the FDA Adverse Events Reporting System due to neuropsychiatric adverse events. FDA is evaluating the needs for regulatory action according to their site. Any opinion on this? Sales of Orlistat dropped due to the liver damage it caused. Any research in regards to C-103 and the liver?
https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm565425.htm